Antitumor activity of Bortezomib alone and in combination with TRAIL in human acute myeloid leukemia.

被引：0
|
作者：
Conticello, Concetta [1 ]
Adamo, Luana [2 ]
Vicari, Luisa [2 ]
Giuffrida, Raffaella [2 ]
Iannolo, Gioacchin [2 ]
Anastasi, Gabriele [2 ]
Palumbo, Giuseppe A. [4 ]
Gulisano, Massimo [2 ]
De Maria, Ruggero [3 ]
Giustolisi, Rosario [4 ]
Di Raimondo, Francesco [4 ]
机构：
[1] Mediterranean Inst Oncol, Dept Expt Oncol, Viagrande, CT USA
[2] IOM Ric, Viagrande, CT USA
[3] Inst Superiore Sanita, Dept Hematol Oncol & Mol Med, Rome, Italy
[4] Univ Catania, Dept Biomed Sci, Hematol Sect, Catania, Italy
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4307.4307
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4307
引用
收藏
页码：144B / 144B
页数：1
相关论文
共 50 条
  • [41] CEBPα mutations in childhood acute myeloid leukemia.
    Liang, DC
    Shih, LY
    Huang, CF
    Hung, IJ
    Yang, CP
    Liu, HC
    Jaing, TH
    Wang, LY
    Chang, WH
    BLOOD, 2004, 104 (11) : 821A - 821A
  • [42] Treatment results of childhood acute myeloid leukemia.
    Liang, DC
    Chang, TT
    Chang, WH
    Lin, KS
    BLOOD, 2003, 102 (11) : 617A - 617A
  • [43] Second primary malignancies in acute myeloid leukemia.
    Nepal, Barsha
    Ghimire, Krishna Bilas
    Shah, Binay Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Karyotype and age in acute myeloid leukemia. Are they linked?
    Moorman, AV
    Roman, E
    Willett, EV
    Dovey, GJ
    Cartwright, RA
    Morgan, GJ
    CANCER GENETICS AND CYTOGENETICS, 2001, 126 (02) : 155 - 161
  • [45] mTOR inhibition in MDR acute myeloid leukemia.
    Karmakar, Aditi
    Gangopadhyay, Sudeshna
    Bhattacharyya, Gouri Shankar
    Mukhopadhyay, Ashis
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] Explore of postremission therapy in acute myeloid leukemia.
    Mi, YC
    Xue, YP
    Wang, JX
    Meng, QX
    Zhao, YZ
    Bian, SG
    BLOOD, 2000, 96 (11) : 214B - 214B
  • [47] Imatinib alone and in combination for chronic myeloid leukemia
    Druker, BJ
    SEMINARS IN HEMATOLOGY, 2003, 40 (01) : 50 - 58
  • [48] AMG 176 exhibits robust antitumor activity in combination with standard of care agents in models of acute myeloid leukemia
    Caenepeel, Sean
    Belmontes, Brian
    Osgood, Tao
    Cajulis, Elaina
    Coxon, Angela
    Canon, Jude
    Hughes, Paul E.
    CANCER RESEARCH, 2019, 79 (13)
  • [49] Adaphostin has significant and selective activity against chronic and acute myeloid leukemia.
    Orsolic, N
    Scappini, B
    Quackenbush, R
    Beran, M
    Giles, F
    Cortes, J
    Kantarjian, H
    Verstovsek, S
    BLOOD, 2002, 100 (11) : 318A - 318A
  • [50] Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia.
    Shoukier, Mahran
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Patel, Keyur P.
    Kadia, Tapan M.
    Ravandi, Farhad
    Ohanian, Maro
    Daver, Naval Guastad
    Issa, Ghayas C.
    Aldrich, Jeffrey
    Borthakur, Gautam
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345